Silexion Therapeutics LTD

0.05
-0.00 (-0.99%)
At close: Apr 16, 2025, 3:58 PM
-0.99%
Bid 0.05
Market Cap 6.87M
Revenue (ttm) n/a
Net Income (ttm) n/a
EPS (ttm) n/a
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.05
Volume 23,478
Avg. Volume (20D) 37,248.637
Open 0.05
Previous Close 0.05
Day's Range 0.05 - 0.06
52-Week Range 0.05 - 0.06
Beta 0.06

About SLXNW

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, ...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 16, 2024
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol SLXNW
Full Company Profile
No News article available yet